Literature DB >> 6300455

Detection of an 85,000-dalton phosphoprotein in ts110 murine sarcoma virus-infected cells with antiserum against a v-mos peptide.

J Papkoff, T Hunter.   

Abstract

We have used an antiserum directed against a synthetic v-mos peptide (anti-C3 serum) to screen ts110 murine sarcoma virus (MuSV)-infected cells for the presence of v-mos-encoded proteins. Anti-C3 serum specifically recognized an 85,000-dalton protein doublet (P85) from [35S]methionine-labeled ts110 MuSV-infected producer cells grown at 32 degrees C, the permissive temperature for transformation. The P85 doublet was also recognized by an antiserum directed against the viral gag protein p15. P85 was present but at 2- to 10-fold-lower levels in ts110 MuSV-infected producer cells grown at 39 degrees C, the restrictive temperature for transformation. The P85gag-mos fusion product was the only v-mos protein reproducibly detected in this ts110 MuSV-transformed cell line. Immunoprecipitation of 32P-labeled cells with anti-C3 serum revealed that the upper band of the P85 doublet is phosphorylated, containing mostly phosphoserine and some phosphothreonine. Cells acutely infected with ts110 MuSV contained slightly higher levels of P85 than did the ts110 MuSV-infected producer cell line. Anti-C3 serum specifically recognized a 33,000-dalton protein (p33) in the acutely infected cells labeled with [35S]methionine. p33 was present in trace amounts and may represent a previously unidentified ts110 MuSV-encoded v-mos protein.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300455      PMCID: PMC256530     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  The isolation and preliminary characterization of temperature-sensitive transformation mutants of Moloney sarcoma virus.

Authors:  D G Blair; M A Hull; E A Finch
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

2.  A virus-induced rhabdomyosarcoma of mice.

Authors:  J B Moloney
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

3.  Characterization of integrated Moloney Sarcoma proviruses and flanking host sequences cloned in bacteriophage lambda.

Authors:  G F Vande Woude; M Oskarsson; W L McClements; L W Enquist; D G Blair; P J Fischinger; J V Maizel; M Sullivan
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1980

4.  Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus.

Authors:  E P Reddy; M J Smith; E Canaani; K C Robbins; S R Tronick; S Zain; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Molecular cloning of unintegrated Moloney mouse sarcoma virus DNA in bacteriophage lambda.

Authors:  I M Verma; M H Lai; R A Bosselman; M A McKennett; H Fan; A Berns
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

6.  In vitro translation of virion RNA from Moloney murine sarcoma virus.

Authors:  J Papkoff; T Hunter; K Beemon
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

7.  Partial characterization of a moloney murine sarcoma virus 85,000-dalton polypeptide whose expression correlates with the transformed phenotype in cells infected with a temperature-sensitive mutant virus.

Authors:  J P Horn; T G Wood; D G Blair; R B Arlinghaus
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

8.  Biological activity of cloned Moloney sarcoma virus DNA: Terminally redundant sequences may enhance transformation efficiency.

Authors:  D G Blair; W L McClements; M K Oskarsson; P J Fischinger; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

9.  A defined subgenomic fragment of in vitro synthesized Moloney sarcoma virus DNA can induce cell transformation upon transfection.

Authors:  P Andersson; M P Goldfarb; R A Weinberg
Journal:  Cell       Date:  1979-01       Impact factor: 41.582

10.  The transforming gene of Moloney murine sarcoma virus.

Authors:  E Canaani; K C Robbins; S A Aaronson
Journal:  Nature       Date:  1979-11-22       Impact factor: 49.962

View more
  3 in total

1.  Complete c-mos (rat) nucleotide sequence: presence of conserved domains in c-mos proteins.

Authors:  F A van der Hoorn; J Firzlaff
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

2.  Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.

Authors:  J Papkoff; G M Ringold
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

3.  P85: a gag-mos polyprotein encoded by ts110 Moloney murine sarcoma virus.

Authors:  L H Stanker; G E Gallick; W S Kloetzer; E C Murphy; R B Arlinghaus
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.